Acetylation of conserved lysines in bovine papillomavirus E2 by p300
Student Authors
Edward QuinlanAcademic Program
Immunology and VirologyDocument Type
Journal ArticlePublication Date
2013-02-01Keywords
AcetylationAnimals
Bovine papillomavirus 1
Cattle
Cell Line
DNA-Binding Proteins
*Gene Expression Regulation, Viral
*Host-Pathogen Interactions
Lysine
*Transcription, Genetic
Viral Proteins
p300-CBP Transcription Factors
Amino Acids, Peptides, and Proteins
Immunopathology
Molecular Genetics
Virology
Viruses
Metadata
Show full item recordAbstract
The p300, CBP, and pCAF lysine acetyltransferase (KAT) proteins have been reported to physically interact with bovine (BPV) and human (HPV) papillomavirus E2 proteins. While overexpression of these KAT proteins enhances E2-dependent transcription, the mechanism has not been determined. Using RNA interference (RNAi) to deplete these factors, we demonstrated that E2 transcriptional activity requires physiological levels of p300, CBP, and pCAF. Each protein appears to have a unique function in E2-dependent transcription, since overexpression of one KAT failed to compensate for RNAi knockdown of another KAT. Using an in vitro acetylation assay, we identified highly conserved lysines that are targeted by p300 for acetylation. The conservative changes of lysines at positions 111 and 112 to arginine were of particular interest. The K111R and the K111R/K112R mutants showed reduced transcriptional activity that was not responsive to p300 overexpression, while the K112R mutant retained activity. p300 and CBP were detected at the viral promoter; however, pCAF was not. We propose a model by which E2 transcriptional activity is controlled by p300-mediated acetylation of lysine 111. This model represents a novel mechanism regulating papillomavirus gene expression.Source
J Virol. 2013 Feb;87(3):1497-507. doi: 10.1128/JVI.02771-12. Epub 2012 Nov 14. Link to article on publisher's site
DOI
10.1128/JVI.02771-12Permanent Link to this Item
http://hdl.handle.net/20.500.14038/29758PubMed ID
23152516Notes
Co-author Edward Quinlan is a student in the Immunology and Virology Program in the Graduate School of Biomedical Sciences (GSBS) at UMass Medical School.
Related Resources
Rights
Publisher PDF posted as allowed by the publisher's author rights policy at http://journals.asm.org/site/misc/ASM_Author_Statement.xhtml.ae974a485f413a2113503eed53cd6c53
10.1128/JVI.02771-12